David Raben - Net Worth and Insider Trading

David Raben Net Worth

The estimated net worth of David Raben is at least $1 Million dollars as of 2026-09-10. David Raben is the Chief Medical Officer of Bicara Therapeutics Inc and owns about 55,286 shares of Bicara Therapeutics Inc (BCAX) stock worth over $1 Million. Details can be seen in David Raben's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Raben has not made any transactions after 2026-04-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David Raben

To

Are these stocks worth buying? — GuruFocus analysis for each holding

David Raben Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Raben owns 1 companies in total, including Bicara Therapeutics Inc (BCAX) .

Click here to see the complete history of David Raben’s form 4 insider trades.

Insider Ownership Summary of David Raben

Ticker Company Transaction Date Type of Owner
BCAX Bicara Therapeutics Inc 2026-04-27 Chief Medical Officer

David Raben Latest Holdings Summary

David Raben currently owns a total of 1 stock. David Raben owns 55,286 shares of Bicara Therapeutics Inc (BCAX) as of April 27, 2026, with a value of $1 Million.

Latest Holdings of David Raben

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCAX Bicara Therapeutics Inc 2026-04-27 55,286 23.64 1,306,961

Holding Weightings of David Raben


David Raben Form 4 Trading Tracker

According to the SEC Form 4 filings, David Raben has made a total of 5 transactions in Bicara Therapeutics Inc (BCAX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Bicara Therapeutics Inc is the sale of 5,500 shares on April 27, 2026, which brought David Raben around $125,840.

Insider Trading History of David Raben

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Raben Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock David Raben owns.
View BCAX Analysis

David Raben Ownership Network

Ownership Network List of David Raben

No Data

Ownership Network Relation of David Raben

Insider Network Chart


David Raben Owned Company Details

What does Bicara Therapeutics Inc do?

Who are the key executives at Bicara Therapeutics Inc?

David Raben is the Chief Medical Officer of Bicara Therapeutics Inc. Other key executives at Bicara Therapeutics Inc include Chief Financial Officer Jennifer Larson , Chief Financial Officer Ivan Hyep , and President and COO Ryan Cohlhepp .

Bicara Therapeutics Inc (BCAX) Insider Trades Summary

Over the past 18 months, David Raben made 5 insider transaction in Bicara Therapeutics Inc (BCAX) with a net sale of 60,500. Other recent insider transactions involving Bicara Therapeutics Inc (BCAX) include a net sale of 198,000 shares made by Ryan Cohlhepp , a net sale of 150,900 shares made by Ivan Hyep , and a net sale of 200,000 shares made by Claire Mazumdar .

In summary, during the past 3 months, insiders sold 108,000 shares of Bicara Therapeutics Inc (BCAX) in total and bought 0 shares, with a net sale of 108,000 shares. During the past 18 months, 754,011 shares of Bicara Therapeutics Inc (BCAX) were sold and 300,000 shares were bought by its insiders, resulting in a net sale of 454,011 shares.

Bicara Therapeutics Inc (BCAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bicara Therapeutics Inc Insider Transactions

No Available Data

David Raben Mailing Address

Above is the net worth, insider trading, and ownership report for David Raben. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Raben's mailing address is: Boston Ma 02116.